In parenteral nutrition-fed piglets, fatty acids vary by lipid emulsion and tissue sampled
- PMID: 37416983
- DOI: 10.1002/jpen.2547
In parenteral nutrition-fed piglets, fatty acids vary by lipid emulsion and tissue sampled
Abstract
Background: Children with intestinal failure without liver disease may be given soy-based lipid emulsion (SLE) or mixed lipid emulsion (MLE; containing soy, medium-chain triglyceride, olive, and/or fish oils). Both differ in essential fatty acid content: MLE has added arachidonic acid (AA) and docosahexaenoic acid (DHA). The aim of this study, in neonatal piglets, was to compare serum and tissue fatty acid composition when the emulsions were given at unrestricted doses.
Methods: We compared SLE (n = 15) and MLE (n = 15) at doses of 10-15 g/kg/day in parenteral nutrition (PN). On day 14 we collected serum and tissues. Using gas-liquid chromatography, percentage fatty acids were measured in serum, brain, and liver phospholipid. Comparisons were made to reference values from litter-matched controls (n = 8).
Results: Comparing median values, linoleic acid (LA) was lower for MLE vs SLE in serum (-27%), liver (-45%), and brain (-33%) (P < 0.001). AA was lower for MLE in serum (-25%), liver (-40%), and brain (-10%). DHA was higher for MLE in serum (+50%), liver (+200%), and brain (+10%). AA levels were lower for MLE vs control piglets in serum (-81%), liver (-63%), and brain (-9%). DHA levels were higher in serum (+41%), liver (+38%), and brain (+19%).
Conclusion: This study in piglets has shown that, at unrestricted doses, MLE treatment is associated with low serum and tissue AA compared with SLE and healthy litter-matched controls. Although not yet proven, low tissue AA levels may have functional consequences, and these data support current practice avoiding MLE dose restriction.
Keywords: fatty acids; gastroenterology; lipids; liver disease; neonates; nutrition assessment; nutrition support teams; parenteral nutrition; pediatrics; short bowel syndrome.
© 2023 The Authors. Journal of Parenteral and Enteral Nutrition published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition.
References
REFERENCES
-
- Lim DW, Turner JM, Wales PW. Emerging piglet models of neonatal short bowel syndrome. JPEN J Parenter Enteral Nutr. 2015;39(6):636-643.
-
- Muto M, Kaji T, Onishi S, Yano K, Yamada W, Ieiri S. An overview of the current management of short-bowel syndrome in pediatric patients. Surg Today. 2022;52(1):12-21.
-
- Diamond IR, de Silva NT, Tomlinson GA, et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enter Nutr. 2011;35(5):596-602.
-
- Pencharz PB. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease. Arch Pediatr Adolesc Med. 2012;166(5):473-478.
-
- Zemrani B, Bines JE. Monitoring of long-term parenteral nutrition in children with intestinal failure. JGH Open. 2019;3(2):163-172.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
